Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
Month: January 2022
Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation
IRVINE, CA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a...
Starton Therapeutics Receives Clinical Trial Authorization in Europe to Initiate Phase 1 Clinical Trial of STAR-LLD Continuous Delivery Lenalidomide
STAR-LLD is the first continuous delivery immunomodulatory drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma...
Biomea Fusion Announces 2022 Clinical Development Plan to Initiate Studies in up to Seven Different Tumor Types and in Diabetes for BMF-219
REDWOOD CITY, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated...
Allogene Therapeutics Announces Removal of FDA Clinical Hold Across All AlloCAR T™ Clinical Trials
Investigation Confirmed the Chromosomal Abnormality in a Single Patient was Not Observed in Any AlloCAR T Product and Not Related...
Veru Announces FDA Grant of Fast Track Designation for Enobosarm for the Treatment of AR+ ER+ HER2- Metastatic Breast Cancer
-- FDA Fast Track Designation is Intended to Expedite the Development and Review of New Drugs to Treat Serious Medical...
CBD of Denver Announces Completion of 2019 and 2020 Audits
Denver, Colorado--(Newsfile Corp. - January 10, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of...
CENTR Files Amended Q1 ’22 Financials Showing Increased Net Income
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Meta Technologies Empowers Private Healthcare with Myriad Health
Myriad Health eliminates bloated corporate partnerships and crushing overhead with the first-ever truly free EHR and billing software VALHALLA, N.Y.--(BUSINESS...
QUANTA Dialysis Technologies Appoints Meghan Fitzgerald and Leslie Norwalk to Board of Directors
ALCESTER, England & BEVERLY, Mass.--(BUSINESS WIRE)--QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a medical technology company committed to making...
Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue
Fourth quarter revenue expected to be in the range of $35.0 million to $35.5 million, representing growth of 30% to...
Signify Health’s New Partnership Program Accelerates Innovation of Care In and Around the Home
Value-based care ecosystem brings together providers, payers, technology and services focused on solutions that close care gaps and drive better...
VitalConnect Announces Closure of $39 Million Round of Growth Financing
Series E Financing led by EW Healthcare Partners with Robert S. White to Join Board SAN JOSE, Calif.--(BUSINESS WIRE)--#vitalconnect--VitalConnect®, Inc.,...
Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results
– Q4 2021 Total Preliminary Revenue of $75.9 to $76.9 million – – Provides Supply Chain and EU Operations Update...
U.S. Digital Health Market Report 2021-2028: Rise in Public-Private Partnerships, Digital Infrastructure Developments, Increasing Healthcare IT Expenditure, and Growing Government Support – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Digital Health Market Size, Share & Trends Analysis Report by Technology (mHealth, Healthcare Analytics, Tele-healthcare), by Component...
Quadient Secures Supplier Status on NHS Shared Business Services Framework Agreement
Quadient included on three Lots for patient/citizen communications and engagement solutions London, 10 January, 2022 Quadient UK, a leader in...
Defence Therapeutics Achieves a Major Milestone and Begins IND-Enabling Testing of Its AccuTOX Lead Compound Against Breast Cancer
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
RepliCel Announces Material Patent Milestones
New DermaPrecise™ patent application and patents granted for tendinopathy and skin rejuvenation technologies in key marketsVANCOUVER, BC / ACCESSWIRE /...
XPhyto Announces New Director of Business Development and Head of Diagnostic Research
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 10, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
MorphoSys To Present At the 40th Annual J.P. Morgan Healthcare Conference
PLANEGG / MUNICH, GERMANY / ACCESSWIRE / Janauary 10, 2022 / MorphoSys AG (FSE:MOR; NASDAQ:MOR), announced today that Jean-Paul Kress,...